Effects of Qidi Tangshen Formulation in treating DKD patients with albuminuria
Phase 1
Recruiting
- Conditions
- diabetic nephropathy
- Registration Number
- ITMCTR2100004852
- Lead Sponsor
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. No limit to gender, aged 30 to 80 years;
2. Meet the diagnostic criteria of diabetic nephropathy, meet the diagnostic criteria of stage 1-2 chronic kidney disease;
3. Accorded with the diagnostic standard of deficiency of both qi and yin and blood stasis blocking collaterals in traditional Chinese medicine;
4. Sign the patient's informed consent form.
Exclusion Criteria
1. Uncontrollable malignant hypertension;
2. Rapid deterioration of renal function recently;
3. Combined with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system, pregnancy;
4. History of adverse reactions to ARB drugs.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rine protein to creatinine ratio;Superoxide dismutase;Malondialdehyde;
- Secondary Outcome Measures
Name Time Method HbA1c;Urinary microparticles;Fasting blood sugar;24h urine protein quantification;Serum creatinine;